The Multiple Myeloma Research Foundation and GNS Healthcare Uncover Novel Drivers of …

NORWALK, Conn. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–The Multiple Myeloma Research Foundation (MMRF), a leader in accelerating the development of breakthrough multiple myeloma therapies, and GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to match health interventions to individual patients and discover new target intervention pathways, today announced initial results from a multi-year collaboration that leverages an unprecedented longitudinal observational study to speed the discovery of innovative treatments for patients with multiple myeloma. From the largest and most comprehensive computer models ever built of molecular and clinical interactions in multiple myeloma disease, potential drivers of clinical outcomes and their associated molecular pathways, including some that may be novel, have begun to emerge. These drivers and molecular pathways may represent targets for drug discovery and development, leading…


Link to Full Article: The Multiple Myeloma Research Foundation and GNS Healthcare Uncover Novel Drivers of …